<unk> , sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva. It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir. In December 2021, the U.S. Food and Drug Administration approved<unk>  for pre-exposure prophylaxis (PrEP) in at-risk people under the brand name Apretude.
Cabotegravir
Maribavir
Saquinavir
Elvitegravir
Dolutegravir
Fosamprenavir
Fostemsavir
Elbasvir